Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis
Cells · 22.03.2023 · 12 (6) · 971
DOI: 10.3390/cells12060971 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 22.03.2023. Verfasst von Hongmei Du und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Induced Pluripotent Stem Cells, Neurodegenerative Diseases. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Province Natural Science Foundation of China, Support Program for Youth Innovation Technology in Colleges and Universities of Shandong Province of China.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that results in the loss of motor function in the central nervous system (CNS) and ultimately death. The mechanisms underlying ALS pathogenesis have not yet been fully elucidated, and ALS cannot be treated effectively. Most studies have applied animal or single-gene intervention cell lines as ALS disease models, but they cannot accurately reflect the pathological characteristics of ALS. Induced pluripotent stem cells (iPSCs) can be reprogrammed from somatic cells, possessing the ability to self-renew and differentiate into a variety of cells. iPSCs can be obtained from ALS patients with different genotypes and phenotypes, and the genetic background of the donor cells remains unchanged during reprogramming. iPSCs can differentiate into neurons and glial cells related to ALS. Therefore, iPSCs provide an excellent method to evaluate the impact of diseases on ALS patients. Moreover, patient-derived iPSCs are obtained from their own somatic cells, avoiding ethical concerns and posing only a low risk of immune rejection. The iPSC technology creates new hope for ALS treatment. Here, we review recent studies on iPSCs and their applications in disease modeling, drug screening and cell therapy in ALS, with a particular focus on the potential for ALS treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.
- Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.
- Department of Pathology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.
- Harvard Medical School and Harvard Stem Cell Institute, Harvard University, Boston, MA 02115, USA.
- Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Yanchun Chen, Xuemei Wang, Jinmeng Liu, Lingyun Zhang, Shuanhu Zhou, Yingjun Guan
Förderung
- National Natural Science Foundation of China
- Shandong Province Natural Science Foundation of China
- Support Program for Youth Innovation Technology in Colleges and Universities of Shandong Province of China
- Student Innovation Fund of Weifang Medical University
Zitieren
APA
Du, H., Huo, Z., Chen, Y., Zhao, Z., Meng, F., Wang, X., Liu, S., Zhang, H., Zhou, F., Liu, J., Zhang, L., Zhou, S., Guan, Y., & Wang, X. (2023). Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis. Cells, 12(6), 971. https://doi.org/10.3390/cells12060971
Vancouver
Du H, Huo Z, Chen Y, Zhao Z, Meng F, Wang X, et al. Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis. Cells. 2023;12(6):971. doi:10.3390/cells12060971
BibTeX
@article{Du2023,
author = {Du, Hongmei and Huo, Zijun and Chen, Yanchun and Zhao, Zhenhan and Meng, Fandi and Wang, Xuemei and Liu, Shiyue and Zhang, Haoyun and Zhou, Fenghua and Liu, Jinmeng and Zhang, Lingyun and Zhou, Shuanhu and Guan, Yingjun and Wang, Xin},
title = {Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis},
journal = {Cells},
year = {2023},
volume = {12},
number = {6},
pages = {971},
doi = {10.3390/cells12060971}
}
EUVIMED